GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Diaceutics DXRX.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

183.50p

-3.42%

Close of 20 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Diaceutics — daily DXRX

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Diaceutics on TradingView ↗
Market value
£155.8m
Last close × shares
Volume
899.6k
Shares, 20 Nov 2026

About Diaceutics

Its shares trade on LSE under the ticker DXRX.L. It has been listed since 21 March 2019. In the fiscal year to 31 December 2024, it reported revenue of £32.2m and a net loss of £1.7m. At that date it held total assets of £48.6m and shareholders' equity of £39.9m.

Diaceutics Plc provides data, data analytics and implementation services. The company is headquartered in Belfast, Northern Ireland. The company went IPO on 2019-03-21. The firm offers end to end services that encompasses from understanding the diagnostic landscape to test implementation into treatment pathways to enable better treatment decisions for patients. The Company’s data analytics and implementation services, including Landscape, Tracking, and Primary Market Research, leverages the diagnostic testing information to provide data-driven insights to drive seamless integration of diagnostic tests into treatment pathways. Its implementation services include Planning, Commercialization and Reimbursement Landscapes, to build the strategies and implement the tactics that drives optimal test utilization, ensuring that patients are getting the right treatment.

Figures and description from our data supplier, not checked against the company's own report.

More about Diaceutics →

Latest on Diaceutics

Our reporting

Next results

15 Mar 2027

Due on 15 Mar 2027. Analysts expect earnings of 0.03 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Diaceutics's ticker?

Diaceutics trades as DXRX.L on LSE, under ISIN GB00BJQTGV64.

What was Diaceutics's last closing price?

183.50p on 20 Nov 2026. The figure is in GBp and is never converted.

When does Diaceutics next report results?

Results are expected on 15 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.